Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
Or call 0345 90 80 161
30 August 2017 09:07
A new drug may carry a boost for heart attack and cancer patients
A study has discovered that a new drug could help cut cancer deaths, as well as potentially reduce the risk of heart attacks.
More than 10,000 patients, all of whom had previously had a heart attack but had not been diagnosed with cancer, took part in a trial using the anti-inflammatory Canakinumab.
They were treated once every three months and monitored for four years.
Milestone in a long journey
It was found that there was a 15% reduction in the risk of heart attacks and strokes, while cancer deaths were cut in half.
Commenting on the study, which was presented at the European Society of Cardiology meeting in Barcelona, Dr Paul Ridker of Brigham and Women's Hospital in Boston said it "represents a milestone in a long journey".
"For the first time, we've been able to definitively show that lowering inflammation independent of cholesterol reduces cardiovascular risk," he said.
"This has far-reaching implications. It tells us that by leveraging an entirely new way to treat patients - targeting inflammation - we may be able to significantly improve outcomes for certain very high-risk populations."
He added that further research is needed into the drug's effects on cancer.
A platform for the future
Gary Gibbons, director of the National Heart, Lung and Blood Institute, said the results provide a platform on which to carry out further trials and research.
He added that while the trial offers "compelling evidence" that targeting inflammation efficacy is preventing recurrent cardiovascular events, the Institute is also looking forward to findings from additional trials, including the NHLBI-funded Cardiovascular Inflammation Reduction Trial, to help further refine the best therapeutic strategies for preventing heart disease.
People who have undergone cancer treatment in the past can arrange specialist medical travel insurance when taking holidays.
17 May 2019
What makes the Monaco Grand Prix so special? From a royal guestlist to a challenging circuit, we take a look at why the Monte Carlo Formula 1 race is so prestigious...
[more...]
15 May 2019
Get inspired for a summer of music, travel and adventure with our guide to some of the best music festivals around Europe.
07 May 2019
Thinking of visiting Spain? There are some excellent reasons to explore the country this spring and summer, from football finals to eating snails - so don't miss out!
Want to learn a new language without the hassle of going to classes? Check out our guide to the best free apps on the market and get yourself holiday-ready in no time.
03 May 2019
Why are there two bank holidays in May? Why do we celebrate May Day? These questions and more are answered in our look at the origins of the May bank holidays...
30 April 2019
Experience the magic of Matera! The 2019 European Capital of Culture, Southern Italy's famous ancient city of caves is the perfect place for a weekend away.
Get inspired for a last-minute getaway this bank holiday weekend! We explore five alternative European city break destinations perfect for a weekend away.
18 April 2019
How much do you know about Spain? Read up on some fascinating facts about Spain and learn more about magical mice, liquid gold and big pay-outs.
16 April 2019
Keen to see first-hand who gets crowned champions of Europe? Europe's biggest football match takes place in Madrid: here's your guide to everything you need to know.
Going away with your children? Beat the stress of travelling with your family with these great travel tips. Here's what you need to know if you're travelling with kids this Easter.
Heading to Madrid? Here's our guide to six must-see places you should visit in the Spanish capital, from food markets to fine art and plenty in between.
10 April 2019
Experience the magic of Madrid's Fiesta de San Isidro 2019! Discover where to stay, what to eat and what to see as you explore one of Spain's greatest festivals.